Pulmonary Nocardiosis Diagnosed by Plasma Metagenomic Next‐Generation Sequencing in a Patient With Recurrent Febrile Neutropenia
Case Reports in Infectious Diseases · 2026-01 · 2026 (1)
DOI: 10.1155/crdi/2832247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Infectious Diseases, online erschienen am 15.07.2026. Verfasst von Maria Vega Brizneda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio, USA, clevelandclinic.org. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background Nocardiosis disproportionately affects immunocompromised hosts. Early identification of Nocardia infections is critical as delays can lead to worse outcomes. Species such as N. farcinica are associated with increased risk of dissemination and resistance. Diagnosis of opportunistic infections in immunocompromised populations relies on culture, antigen, or serologic methods that often have limited sensitivity or specificity. Plasma microbial cell‐free DNA metagenomic next‐generation sequencing (mNGS) offers a noninvasive approach for early diagnosis of opportunistic infections. Case Presentation We report a case of pulmonary nocardiosis in an 87‐year‐old man with myelodysplastic syndrome and prolonged neutropenia diagnosed by plasma mNGS. He had been hospitalized multiple times with recurrent febrile neutropenia and respiratory symptoms. Standard noninvasive microbiologic workup was unrevealing, but lower respiratory specimens could not be readily obtained. Due to elevated risk of complications from invasive testing, plasma mNGS was used as a complementary tool and identified N. farcinica . Anti‐ Nocardia therapy was initiated, and his fevers resolved. Conclusion mNGS is an emerging diagnostic tool that may identify Nocardia species from clinical specimens with a faster turnaround time than culture and enables rapid species identification. Although culture is still recommended for susceptibility testing, mNGS may expedite diagnosis in particular situations. This case supports the role of plasma mNGS as a complementary tool in the evaluation of febrile neutropenia and highlights its diagnostic potential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio, USA, clevelandclinic.org.
- Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA, clevelandclinic.org.
ORCID-Profile: Maria Vega Brizneda, Jessica Lum, Hannah Wang, Zachary A Yetmar
Zitieren
APA
Vega Brizneda, M., Lum, J., Wang, H., & Yetmar, Z. A. (2026). Pulmonary Nocardiosis Diagnosed by Plasma Metagenomic Next‐Generation Sequencing in a Patient With Recurrent Febrile Neutropenia. Case Reports in Infectious Diseases, 2026(1). https://doi.org/10.1155/crdi/2832247
Vancouver
Vega Brizneda M, Lum J, Wang H, Yetmar ZA. Pulmonary Nocardiosis Diagnosed by Plasma Metagenomic Next‐Generation Sequencing in a Patient With Recurrent Febrile Neutropenia. Case Reports in Infectious Diseases. 2026;2026(1). doi:10.1155/crdi/2832247
BibTeX
@article{VegaBrizneda2026,
author = {Vega Brizneda, Maria and Lum, Jessica and Wang, Hannah and Yetmar, Zachary A},
title = {Pulmonary Nocardiosis Diagnosed by Plasma Metagenomic Next‐Generation Sequencing in a Patient With Recurrent Febrile Neutropenia},
journal = {Case Reports in Infectious Diseases},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crdi/2832247}
}
EUVIMED